BPC-157 vs CJC-1295

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

BPC-157

Body Protection Compound-157 is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in research studies.

Full details →

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

Side-by-Side Comparison

AspectBPC-157CJC-1295
MechanismBPC-157 works through multiple pathways including upregulation of growth factor expression, nitric oxide system modulation, and promotion of angiogenesis. It enhances tendon-to-bone healing and supports the formation of new blood vessels.CJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.
Typical DosageTypical research dosages range from 250-500mcg administered 1-2 times daily. Both subcutaneous and oral administration have been studied.CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.
AdministrationCan be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable.Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.
Side EffectsGenerally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses.Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.
Best For

What They Have in Common

Both BPC-157 and CJC-1295 are commonly used for:

Key Differences

Detailed Analysis

Both BPC-157 and CJC-1295 are commonly used for Muscle Growth.

Which Should You Choose?

CJC-1295 has stronger evidence for Muscle Growth.

Ready to Learn More?